AGMB - Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.